Sandostatin LAR Depot 10 mg powder for injection Images
Generic Name: octreotide
This medication has been identified as Sandostatin LAR Depot 10 mg powder for injection. It is supplied by Novartis Pharmaceuticals Corporation.
Sandostatin LAR Depot is used in the treatment of Carcinoid Tumor; Acromegaly; Vasoactive Intestinal Peptide Tumor and belongs to the drug class somatostatin and somatostatin analogs. There is no proven risk in humans during pregnancy. Sandostatin LAR Depot 10 mg powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Sandostatin LAR Depot
- Generic Name
- octreotide
- Strength
- 10 mg powder for injection
- Availability
- Prescription only
- Drug Class
- Somatostatin and somatostatin analogs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0790
More about Sandostatin LAR Depot (octreotide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
